Navigation Links
Paradigm is Successful at Annual Vision Source Meeting in Houston, Texas
Date:4/27/2011

SALT LAKE CITY, April 27, 2011 /PRNewswire/ -- Paradigm Medical Industries, Inc. (OTC: PDMI.PK) announced its success at the annual meeting of Vision Source, an optometric organization, which was held at the Houston Convention Center in Houston, Texas from April 14-17, 2011.  Over 2,300 private practice optometrists from many of the most highly regarded practices in the United States were in attendance at the annual meeting.  The meeting provided opportunities for participating optometrists to attend practice building seminars, benefit from shared peer experience, and purchase equipment from vendors approved by Vision Source.

"This important annual meeting with Vision Source's members resulted in creating many new sales opportunities for Paradigm's products, including the Blood Flow Analyzer™, the P60 UBM Ultrasound Biomicroscope, the new LD 500 autoperimeter, and the new Paramax™.  New sales were made and numerous quality leads that will lead to future sales made the meeting a great success," said Stephen L. Davis, Paradigm's President and Chief Executive Officer.

Mr. Davis added, "The opportunity to attend the meeting filled an important sales objective for Paradigm to reestablish its working relationship with the Vision Source group and introduce Paradigm's high technology diagnostic eye care instruments for early detection of glaucoma and other eye disorders to this important professional eye care group."

Vision Source is an invitation only, private optometric organization that requires its members to pay an annual membership fee to belong and benefit from its membership.  Members learn new practice building skills, improve staff development, and gain valuable general business tips.  Members also enjoy reduced pricing from approved vendors who financially support these efforts.  

About Paradigm Medical Industries, Inc.

Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes ophthalmic diagnostic instruments and related products for early detection of glaucoma and other eye disorders. The Company's primary objective is to capture a niche market within the glaucoma and ultrasound microscopy fields. The Company markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States and internationally.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.

Contact: Stephen L. Davis
President and Chief Executive Officer
801-977-8970
www.paradigm-medical.com


'/>"/>
SOURCE Paradigm Medical Industries, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. RSB Spine, LLC, Announces Distribution Agreement with Paradigm BioDevices, Inc.
2. Study Results Present Paradigm Shift; REDUCE Trial Shows New Hope for the Risk Reduction of Prostate Cancer
3. Changing Paradigms in Hereditary Angioedema: A Focus on Prompt Diagnosis and New Therapies
4. Topical Treatment for Cold Sores Achieves Efficacy of Oral Drugs; Represents Paradigm Shift in the Treatment of Skin Infections
5. Siemens Applauds First Health System Customers to Successfully Attest to Meaningful Use
6. Reportlinker Adds Successful Strategies for Drug Repositioning
7. Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
8. Creating a Road Map for Successful Metabolic New Product Launches
9. Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
10. Champions Biotechnology Exercises Option to License Proprietary Compound Based on Successful Tumorgraft™ Test Results
11. Successful Strategies and Innovative Practices for Bringing FDC Products to Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... -- Research and Markets has announced the addition ... Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and ... ... Market Sales Volume, Company Analysis and Forecast to 2022 provides ... The growing prevalence of hearing impairment coupled with ...
(Date:1/20/2017)... N.Y. , Jan. 20, 2017  Palladian ... programs, has announced the launch of an opioid ... new guidelines on opioids and helps stem the ... are often prescribed to treat chronic non-cancer pain ... despite serious risks and lack of evidence regarding ...
(Date:1/19/2017)... , Jan. 19, 2017 ... Summary GlobalData,s new report, "Germany Cataract Surgery ... on the Germany Cataract Surgery Devices market. The report ... units) and average prices (USD) within market segements - ... report also provides company shares and distribution shares data ...
Breaking Medicine Technology:
(Date:1/20/2017)... , ... January 20, 2017 , ... A new partnership ... items they no longer use or need, from clothes to couches to dressers and ... items and take them to the nearest Goodwill donation center through February 28th. ...
(Date:1/20/2017)... ... , ... Source Vitál Apothecary, a skin and body care company dedicated to ... had a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition Conference ... the nutritional, sports and health industries a chance to meet in private sessions with ...
(Date:1/20/2017)... ... ... Bionic Sports Nutrition LLC, an American company devoted to developing high-quality nutritional ... ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition manufactures its ... products to all clients at reasonable prices. At the ECRM trade show, it had ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, ... everyday lives, recently attended the January ECRM Trade Show in Hilton Head, SC, ... for its large range of supplements that keep the body functioning at its ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):